Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 20% ± 3% | |
plasmacytoid dendritic cell | 5 studies | 22% ± 3% | |
B cell | 4 studies | 19% ± 2% | |
classical monocyte | 4 studies | 20% ± 4% | |
fibroblast | 4 studies | 19% ± 3% | |
conventional dendritic cell | 3 studies | 22% ± 4% | |
myeloid cell | 3 studies | 26% ± 4% | |
epithelial cell | 3 studies | 36% ± 5% | |
macrophage | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 17% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2609.25 | 1445 / 1445 | 100% | 14.44 | 183 / 183 |
lung | 100% | 2462.31 | 578 / 578 | 100% | 15.02 | 1155 / 1155 |
ovary | 100% | 2036.45 | 180 / 180 | 100% | 12.07 | 430 / 430 |
skin | 100% | 3819.88 | 1809 / 1809 | 100% | 22.11 | 472 / 472 |
stomach | 100% | 1612.43 | 359 / 359 | 100% | 9.88 | 286 / 286 |
uterus | 100% | 2127.77 | 170 / 170 | 100% | 20.21 | 459 / 459 |
kidney | 100% | 1795.21 | 89 / 89 | 100% | 15.47 | 899 / 901 |
bladder | 100% | 2463.48 | 21 / 21 | 100% | 15.23 | 502 / 504 |
thymus | 100% | 1637.42 | 651 / 653 | 100% | 14.64 | 604 / 605 |
brain | 99% | 1555.86 | 2628 / 2642 | 100% | 18.13 | 705 / 705 |
breast | 100% | 3391.13 | 459 / 459 | 99% | 17.90 | 1112 / 1118 |
prostate | 100% | 1710.99 | 245 / 245 | 99% | 12.89 | 499 / 502 |
intestine | 100% | 2482.76 | 966 / 966 | 99% | 10.29 | 523 / 527 |
adrenal gland | 100% | 2034.87 | 258 / 258 | 98% | 10.22 | 225 / 230 |
liver | 97% | 888.36 | 219 / 226 | 99% | 9.25 | 401 / 406 |
pancreas | 94% | 823.75 | 308 / 328 | 99% | 14.80 | 177 / 178 |
adipose | 100% | 4230.98 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2813.56 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.16 | 29 / 29 |
spleen | 100% | 1914.45 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.72 | 1 / 1 |
muscle | 99% | 1318.61 | 795 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1404.21 | 830 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 10.10 | 77 / 80 |
peripheral blood | 94% | 1597.91 | 873 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043200 | Biological process | response to amino acid |
GO_1903432 | Biological process | regulation of TORC1 signaling |
GO_0009267 | Biological process | cellular response to starvation |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0008380 | Biological process | RNA splicing |
GO_0061462 | Biological process | protein localization to lysosome |
GO_0007264 | Biological process | small GTPase-mediated signal transduction |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0006915 | Biological process | apoptotic process |
GO_0008104 | Biological process | protein localization |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0032006 | Biological process | regulation of TOR signaling |
GO_0072657 | Biological process | protein localization to membrane |
GO_0005764 | Cellular component | lysosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990131 | Cellular component | Gtr1-Gtr2 GTPase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990877 | Cellular component | FNIP-folliculin RagC/D GAP |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0019003 | Molecular function | GDP binding |
GO_0043495 | Molecular function | protein-membrane adaptor activity |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0140767 | Molecular function | enzyme-substrate adaptor activity |
GO_0051020 | Molecular function | GTPase binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0005525 | Molecular function | GTP binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RRAGC |
Protein name | Ras-related GTP-binding protein C (Rag C) (RagC) (EC 3.6.5.-) (GTPase-interacting protein 2) (TIB929) |
Synonyms | |
Description | FUNCTION: Guanine nucleotide-binding protein that plays a crucial role in the cellular response to amino acid availability through regulation of the mTORC1 signaling cascade . Forms heterodimeric Rag complexes with RagA/RRAGA or RagB/RRAGB and cycles between an inactive GTP-bound and an active GDP-bound form: RagC/RRAGC is in its active form when GDP-bound RagC/RRAGC forms a complex with GTP-bound RagA/RRAGA (or RagB/RRAGB) and in an inactive form when GTP-bound RagC/RRAGC heterodimerizes with GDP-bound RagA/RRAGA (or RagB/RRAGB) . In its GDP-bound active form, promotes the recruitment of mTORC1 to the lysosomes and its subsequent activation by the GTPase RHEB . This is a crucial step in the activation of the MTOR signaling cascade by amino acids . Also plays a central role in the non-canonical mTORC1 complex, which acts independently of RHEB and specifically mediates phosphorylation of MiT/TFE factors TFEB and TFE3: GDP-bound RagC/RRAGC mediates recruitment of MiT/TFE factors TFEB and TFE3 . . |
Accessions | ENST00000373001.4 Q9HB90 |